The Centers for Disease Control and Prevention yesterday released recommendations for the ethical allocation of COVID-19 vaccines, once available to the public.

CDC’s Advisory Committee on Immunization Practices identified four ethical principles on which to base allocation recommendations while supplies of COVID-19 vaccines are limited — maximizing benefits and minimizing harms, promoting justice, mitigating health inequities, and promoting transparency.

The committee notes that such consideration must be viewed in the context of science (e.g., available information about the vaccines’ characteristics, including safety and efficacy in older adults and epidemiologic risk) and feasibility of implementation (e.g., storage and handling requirements).

Related News Articles

Headline
The Centers for Disease Control and Prevention Dec. 11 released a report that found last year’s version of the COVID-19 vaccine was 76% effective in preventing…
Headline
The AHA provided recommendations to the Food and Drug Administration Dec. 1 in response to a request for information on the measurement and evaluation of…
Headline
The Food and Drug Administration has identified a Class I recall of Baxter Life2000 Ventilation Systems due to a cybersecurity issue discovered through…
Headline
Flu cases are growing or likely growing in 39 states, according to the latest Centers for Disease Control and Prevention data from Nov. 11. COVID-19…
Headline
The Food and Drug Administration yesterday published an announcement from Otsuka ICU Medical saying that the company issued a voluntary recall for a mislabeled…
Headline
A study published Oct. 30 by the American Heart Association found that people have an elevated risk of heart attack and stroke following flu and COVID-19…